Related Experiment Video
Updated: Sep 18, 2025

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Opportunistic Fungal Infections in Sub-Saharan Africa
Lucian Duvenage1,2,3, Emily Ruth Higgitt1,4,5, Rachael Dangarembizi1,4,5
1CMM AFRICA Medical Mycology Research Unit, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; email: lucian.duvenage@uct.ac.za, jennifer.hoving@uct.ac.za.
Opportunistic fungal infections, particularly Cryptococcus neoformans and Pneumocystis jirovecii, cause significant deaths in sub-Saharan Africa. Addressing unique regional risks and research gaps is crucial to reduce this fungal disease burden.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Opportunistic fungal infections are a leading cause of death in sub-Saharan Africa.
- High rates of advanced HIV disease and limited healthcare access exacerbate fungal disease burden.
- Underreported endemic fungal pathogens pose significant threats.
Purpose of the Study:
- To review key fungal pathogens contributing to mortality in sub-Saharan Africa.
- To discuss advances in understanding fungal pathogenesis for novel therapies.
- To highlight regional risk factors, diagnostic/treatment challenges, and research priorities.
Main Methods:
- Literature review focusing on high-mortality fungal pathogens.
- Analysis of pathogenesis, risk factors, and treatment challenges in sub-Saharan Africa.
- Identification of research priorities for fungal disease control.
Main Results:
- Cryptococcus neoformans, Pneumocystis jirovecii, Histoplasma spp., and Emergomyces africanus are major contributors to mortality.
- Understanding pathogenesis offers potential for new antifungal drug development.
- Sub-Saharan Africa faces unique challenges in fungal disease diagnosis and treatment.
Conclusions:
- Urgent research is needed to address the significant burden of fungal infections in sub-Saharan Africa.
- Novel diagnostics and therapeutics are essential to reduce fungal-related morbidity and mortality.
- Targeted strategies are required to mitigate risks associated with HIV-related fungal diseases.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Ascomycota
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

